Tanning Peptides

Activate Your Melanin.
Deep. Even. Natural.

Tanning peptides work by mimicking alpha-melanocyte stimulating hormone (α-MSH) — the body's own tanning signal. By binding melanocortin receptors directly, Melanotan II and PT-141 drive eumelanin synthesis in melanocytes without requiring UV radiation as the primary trigger.

MC1R
Primary receptor driving eumelanin synthesis
4
Injections to produce visible tanning (clinical)
2.7h
PT-141 half-life — longer-lasting effect
Phase III
PT-141 (bremelanotide) FDA clinical pathway

How Melanocortin Tanning Peptides Work

Natural Tanning vs. Peptide Tanning

Natural UV tanning begins when UVB radiation damages DNA in melanocytes, triggering a stress response that upregulates α-MSH. This α-MSH then activates MC1R, driving melanin synthesis. The problem: you need the UV damage first. And the initial melanin response under UV stimulation initially favors pheomelanin (reddish, less protective) before converting to eumelanin.

Melanocortin peptides like Melanotan II skip the UV damage step entirely. They bind MC1R directly, activating melanin synthesis without the prerequisite cellular stress — and they preferentially drive eumelanin (the dark, photoprotective melanin) production from the start.

The University of Arizona Research

Melanotan II emerged from a University of Arizona research program led by Drs. Mac Hadley and Victor Hruby, initially developed as a potential skin cancer prevention agent. The rationale: if melanin provides natural photoprotection, could controlled melanin upregulation without UV damage reduce skin cancer risk?

Phase I clinical trials (Levine et al., 1991; Hadley et al., 1998) demonstrated dose-dependent tanning in fair-skinned volunteers, establishing the safety and efficacy profile that forms the clinical basis for current use. Subsequent Phase I/II work confirmed the receptor mechanism and dose-response relationship.

Melanocortin Receptor Biology

Understanding which receptor drives which effect explains both the tanning benefits and the side effects of melanocortin peptides.

MC1RMelanocytes (skin)

Melanin synthesis — drives eumelanin (dark) over pheomelanin (red)

Primary tanning mechanism

MC3RBrain, adipose tissue

Energy homeostasis, appetite regulation, anti-inflammatory

Secondary — fat loss synergy

MC4RCentral nervous system

Satiety, libido, pro-erectile effects (males), mood regulation

Secondary — libido and appetite effects

MC5RExocrine glands, skeletal muscle

Sebaceous gland secretion, some immune modulation

Tertiary — minor relevance

Melanotan II vs. PT-141 — Side-by-Side Comparison

PropertyMelanotan IIPT-141Edge
Primary receptor targetsMC1R, MC3R, MC4R, MC5RMC3R, MC4R (primary)MT-II
Tanning potencyHigh — strong MC1R agonismModerate — lower MC1R affinityMT-II
Nausea profileModerate–High (dose dependent)Mild–Moderate (significantly less)PT-141
Half-life~1 hour (frequent redosing)~2.7 hours (more sustained)PT-141
FDA evaluationPhase I/II only (University of Arizona)Phase III (approved as Vyleesi)PT-141
Appetite suppressionYes — MC4R activationYes — MC4R activationBoth
Best for beginnersNo (stronger side effects)Yes (better tolerated)PT-141
Maximum tanning depthHigher ceiling doseLower ceilingMT-II

Verdict: Choose Melanotan II for maximum tanning depth and pigmentation speed. Choose PT-141 for a gentler introduction to melanocortin peptides with fewer side effects and longer effect duration.

Side Effect Management

Common Side Effects & Causes

  • Nausea

    Cause: MC3R/MC4R activation in brainstem and GI tract

    Management: Start low (0.25mg), administer in evening, titrate slowly

  • Facial flushing

    Cause: Peripheral vasodilation via MC5R and MC3R

    Management: Dose-dependent; reduces with tolerance. Evening dosing minimizes social impact

  • Yawning/fatigue

    Cause: Central MC4R effects

    Management: Evening administration; typically resolves as tolerance develops

  • Spontaneous erections (males)

    Cause: MC4R central effects on erectile tissue

    Management: Dose reduction; effect diminishes with continued use as receptor adaptation occurs

Key Safety Principles

  • Always start at the lowest dose (0.25mg MT-II; 0.5mg PT-141) and titrate based on tolerance
  • Evening administration allows you to sleep through the peak nausea window
  • Do not exceed 2mg per injection — higher doses produce diminishing returns and greater side effects
  • Contraindicated with: certain medications affecting melanocortin signaling, cardiovascular conditions
  • Monitor any moles or skin pigmentation changes — report unusual changes to a dermatologist
  • UV exposure dramatically accelerates tanning response — even 15–20 minutes per day is sufficient
  • Avoid excessive sun exposure without SPF in non-targeted areas during loading phase

Tanning Peptide Protocol Guide

Melanotan II Protocol

Reconstitution

10mg + 2ml bac water = 5,000mcg/ml

0.05ml = 0.25mg | 0.1ml = 0.5mg | 0.2ml = 1mg

Loading (Weeks 1–3)

0.25–0.5mg nightly subcutaneous

Combine with 15–20 min daily UV for best results

Maintenance (Week 4+)

0.5–1mg, 1–2× weekly

Reduce UV requirement once pigmentation established

PT-141 Protocol

Reconstitution

10mg + 2ml bac water = 5,000mcg/ml

0.1ml = 0.5mg | 0.2ml = 1mg | 0.4ml = 2mg

Tanning Protocol

1–2mg, 2–3× weekly subcutaneous

Longer half-life allows less frequent dosing

Beginner Recommendation

Start at 0.5–1mg; assess tolerance before advancing

Better first choice if MT-II nausea was problematic

Tanning Peptides

0 melanocortin peptides — sourced from Apollo